Updated on 2024/11/11

写真a

 
NAWA Yoshihiro
 
Organization
Graduate School of Medicine Department of developmental disability medicine Endowed Chair Designated assistant professor
Title
Designated assistant professor

Degree 1

  1. 博士(医学) ( 2021.3   名古屋大学 ) 

Research Interests 1

  1. 神経発達症

Research Areas 1

  1. Life Science / Genome biology

Professional Memberships 4

  1. 日本小児精神神経学会

  2. 日本臨床精神神経薬理学会

  3. 日本児童青年精神医学会

  4. 日本精神神経学会

 

Papers 13

  1. Analysis of human neuronal cells carrying ASTN2 deletion associated with psychiatric disorders. International journal

    Yu Hayashi, Hiroki Okumura, Yuko Arioka, Itaru Kushima, Daisuke Mori, Tzuyao Lo, Gantsooj Otgonbayar, Hidekazu Kato, Yoshihiro Nawa, Hiroki Kimura, Branko Aleksic, Norio Ozaki

    Translational psychiatry   Vol. 14 ( 1 ) page: 236 - 236   2024.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Recent genetic studies have found common genomic risk variants among psychiatric disorders, strongly suggesting the overlaps in their molecular and cellular mechanism. Our research group identified the variant in ASTN2 as one of the candidate risk factors across these psychiatric disorders by whole-genome copy number variation analysis. However, the alterations in the human neuronal cells resulting from ASTN2 variants identified in patients remain unknown. To address this, we used patient-derived and genome-edited iPS cells with ASTN2 deletion; cells were further differentiated into neuronal cells. A comprehensive gene expression analysis using genome-edited iPS cells with variants on both alleles revealed that the expression level of ZNF558, a gene specifically expressed in human forebrain neural progenitor cells, was greatly reduced in ASTN2-deleted neuronal cells. Furthermore, the expression of the mitophagy-related gene SPATA18, which is repressed by ZNF558, and mitophagy activity were increased in ASTN2-deleted neuronal cells. These phenotypes were also detected in neuronal cells differentiated from patient-derived iPS cells with heterozygous ASTN2 deletion. Our results suggest that ASTN2 deletion is related to the common pathogenic mechanism of psychiatric disorders by regulating mitophagy via ZNF558.

    DOI: 10.1038/s41398-024-02962-4

    Web of Science

    Scopus

    PubMed

  2. Study of the genetic association between selected 3q29 region genes and schizophrenia and autism spectrum disorder in the Japanese population.

    Gantsooj Otgonbayar, Tzuyao Lo, Yu Hayashi, Sho Furuta, Branko Aleksic, Yoshihiro Nawa, Itaru Kushima, Hidekazu Kato, Hiroki Kimura, Norio Ozaki

    Nagoya journal of medical science   Vol. 86 ( 2 ) page: 216 - 222   2024.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Psychiatric disorders are highly inheritable, and most psychiatric disorders exhibit genetic overlap. Recent studies associated the 3q29 recurrent deletion with schizophrenia (SCZ) and autism spectrum disorder (ASD). In this study, we investigated the association of genes in the 3q29 region with SCZ and ASD. TM4SF19 and PAK2 were chosen as candidate genes for this study based on evidence from previous research. We sequenced TM4SF19 and PAK2 in 437 SCZ cases, 187 ASD cases and 524 controls in the Japanese population. Through targeted sequencing, we identified 6 missense variants among the cases (ASD & SCZ), 3 missense variants among controls, and 1 variant common to both cases and controls; however, no loss-of-function variants were identified. Fisher's exact test showed a significant association of variants in TM4SF19 among cases (p=0.0160). These results suggest TM4SF19 variants affect the etiology of SCZ and ASD in the Japanese population. Further research examining 3q29 region genes and their association with SCZ and ASD is thus needed.

    DOI: 10.18999/nagjms.86.2.216

    Scopus

    PubMed

  3. Phenotypes for general behavior, activity, and body temperature in 3q29 deletion model mice

    Daisuke Mori, Ryosuke Ikeda, Masahito Sawahata, Sho Yamaguchi, Akiko Kodama, Takashi Hirao, Yuko Arioka, Hiroki Okumura, Chihiro Inami, Toshiaki Suzuki, Yu Hayashi, Hidekazu Kato, Yoshihiro Nawa, Seiko Miyata, Hiroki Kimura, Itaru Kushima, Branko Aleksic, Hiroyuki Mizoguchi, Taku Nagai, Takanobu Nakazawa, Ryota Hashimoto, Kozo Kaibuchi, Kazuhiko Kume, Kiyofumi Yamada, Norio Ozaki

    Translational Psychiatry   Vol. 14 ( 1 ) page: 138   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    Whole genome analysis has identified rare copy number variations (CNV) that are strongly involved in the pathogenesis of psychiatric disorders, and 3q29 deletion has been found to have the largest effect size. The 3q29 deletion mice model (3q29-del mice) has been established as a good pathological model for schizophrenia based on phenotypic analysis; however, circadian rhythm and sleep, which are also closely related to neuropsychiatric disorders, have not been investigated. In this study, our aims were to reevaluate the pathogenesis of 3q29-del by recreating model mice and analyzing their behavior and to identify novel new insights into the temporal activity and temperature fluctuations of the mouse model using a recently developed small implantable accelerometer chip, Nano-tag. We generated 3q29-del mice using genome editing technology and reevaluated common behavioral phenotypes. We next implanted Nano-tag in the abdominal cavity of mice for continuous measurements of long-time activity and body temperature. Our model mice exhibited weight loss similar to that of other mice reported previously. A general behavioral battery test in the model mice revealed phenotypes similar to those observed in mouse models of schizophrenia, including increased rearing frequency. Intraperitoneal implantation of Nano-tag, a miniature acceleration sensor, resulted in hypersensitive and rapid increases in the activity and body temperature of 3q29-del mice upon switching to lights-off condition. Similar to the 3q29-del mice reported previously, these mice are a promising model animals for schizophrenia. Successive quantitative analysis may provide results that could help in treating sleep disorders closely associated with neuropsychiatric disorders.

    DOI: 10.1038/s41398-023-02679-w

    Web of Science

    Scopus

    PubMed

    Other Link: https://www.nature.com/articles/s41398-023-02679-w

  4. Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study. International journal

    Tzuyao Lo, Itaru Kushima, Hiroki Kimura, Branko Aleksic, Takashi Okada, Hidekazu Kato, Toshiya Inada, Yoshihiro Nawa, Youta Torii, Maeri Yamamoto, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Shusuke Numata, Kiyoto Kasai, Tsukasa Sasaki, Shigeru Yokoyama, Toshio Munesue, Ryota Hashimoto, Yuka Yasuda, Michiko Fujimoto, Masahide Usami, Masanari Itokawa, Makoto Arai, Kazutaka Ohi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Hidenori Yamasue, Nakao Iwata, Masashi Ikeda, Norio Ozaki

    Neuropsychopharmacology reports   Vol. 44 ( 1 ) page: 42 - 50   2023.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    AIM: The present study aimed to examine the association between copy number variations (CNVs) in parkin (PRKN) and schizophrenia (SCZ) and autism spectrum disorder (ASD) in a large case-control sample. METHOD: Array comparative genomic hybridization was performed on 3111 cases with SCZ, 1236 cases with ASD, and 2713 controls. We systematically prioritized likely pathogenic CNVs (LP-CNVs) in PRKN and examined their association with SCZ and ASD. RESULTS: In total, 3014 SCZ cases (96.9%), 1205 ASD cases (97.5%), and 2671 controls (98.5%) passed quality control. We found that monoallelic carriers of LP-CNVs in PRKN were common (70/6890, 1.02%) and were not at higher risk of SCZ (p = 0.29) or ASD (p = 0.72). We observed that the distribution pattern of LP-CNVs in the Japanese population was consistent with those in other populations. We also identified a patient diagnosed with SCZ and early-onset Parkinson's disease carrying biallelic pathogenic CNVs in PRKN. The absence of Parkinson's symptoms in 10 other monoallelic carriers of the same pathogenic CNV further reflects the lack of effect of monoallelic pathogenic variants in PRKN in the absence of a second hit. CONCLUSION: The present findings suggest that monoallelic CNVs in PRKN do not confer a significant risk for SCZ or ASD. However, further studies to investigate the association between biallelic CNVs in PRKN and SCZ and ASD are warranted.

    DOI: 10.1002/npr2.12370

    Web of Science

    Scopus

    PubMed

  5. Analysis of human neuronal cells carrying ASTN2 deletion: A cross-disorder risk variant of schizophrenia, autism spectrum disorder, and bipolar disorder

    Yuko Arioka, Yu Hayashi, Hiroki Okumura, Itaru Kushima, Daisuke Mori, Tzuyao Lo, Gantsooj Otgonbayar, Hidekazu Kato, Yoshihiro Nawa, Hiroki Kimura, Branko Aleksic, Norio Ozaki

        2023.2

     More details

  6. Treatment‐resistant schizophrenia in patients with 3q29 deletion: A case series of four patients Reviewed International journal

    Yoshihiro Nawa, Itaru Kushima, Branko Aleksic, Maeri Yamamoto, Hiroyuki Kimura, Masahiro Banno, Ryota Hashimoto, Norio Ozaki

    Psychiatry and Clinical Neurosciences   Vol. 76 ( 7 ) page: 338 - 339   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/pcn.13361

    Web of Science

    Scopus

    PubMed

  7. Exome sequencing of Japanese schizophrenia multiplex families supports the involvement of calcium ion channels Reviewed

    Miho Toyama, Yuto Takasaki, Aleksic Branko, Hiroki Kimura, Hidekazu Kato, Yoshihiro Nawa, Itaru Kushima, Kanako Ishizuka, Teppei Shimamura, Tomoo Ogi, Norio Ozaki

    PLOS ONE   Vol. 17 ( 5 ) page: e0268321 - e0268321   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Public Library of Science ({PLoS})  

    <jats:sec id="sec001">
    <jats:title>Background</jats:title>
    <jats:p>Most sequencing studies of schizophrenia (SCZ) have focused on <jats:italic>de novo</jats:italic> genetic variants due to interpretability. However, investigating shared rare variants among patients in the same multiplex family is also important. Relatively large-scale analyses of SCZ multiplex families have been done in Caucasian populations, but whether detected variants are also pathogenic in the Japanese population is unclear because of ethnic differences in rare variants.</jats:p>
    </jats:sec>
    <jats:sec id="sec002">
    <jats:title>Materials and methods</jats:title>
    <jats:p>We performed whole-exome sequencing (WES) of 14 Japanese SCZ multiplex families. After quality control and filtering, we identified rare variants shared among affected persons within the same family. A gene ontology (GO) analysis was performed to identify gene categories possibly affected by these candidate variants.</jats:p>
    </jats:sec>
    <jats:sec id="sec003">
    <jats:title>Results</jats:title>
    <jats:p>We found 530 variants in 486 genes as potential candidate variants from the 14 SCZ multiplex families examined. The GO analysis demonstrated significant enrichment in calcium channel activity.</jats:p>
    </jats:sec>
    <jats:sec id="sec004">
    <jats:title>Conclusion</jats:title>
    <jats:p>This study provides supporting evidence that calcium ion channel activity is involved in SCZ. WES of multiplex families is a potential means of identifying disease-associated rare variants for SCZ.</jats:p>
    </jats:sec>

    DOI: 10.1371/journal.pone.0268321

    Web of Science

    Scopus

    PubMed

  8. Investigation of OLIG2 as a candidate gene for schizophrenia and autism spectrum disorder. Reviewed

    Sho Furuta, Branko Aleksic, Yoshihiro Nawa, Hiroki Kimura, Itaru Kushima, Kanako Ishizuka, Hidekazu Kato, Miho Toyama, Yuko Arioka, Daisuke Mori, Mako Morikawa, Toshiya Inada, Norio Ozaki

    Nagoya journal of medical science   Vol. 84 ( 2 ) page: 260 - 268   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A number of genomic mutations that are thought to be strongly involved in the development of schizophrenia (SCZ) and autism spectrum disorder (ASD) have been identified. Abnormalities involving oligodendrocytes have been reported in SCZ, and as a related gene, oligodendrocyte lineage transcription factor 2 (OLIG2) has been reported to be strongly associated with SCZ. In this study, based on the common disease-rare variant hypothesis, target sequencing of candidate genes was performed to identify rare mutations with a high effect size and the possibility that the identified mutations may increase the risks of SCZ and ASD in the Japanese population. In this study, the exon region of OLIG2 was targeted; 370 patients with SCZ and 192 with ASD were subjected to next-generation sequencing. As a result, one rare missense mutation (A33T) was detected. We used the Sanger method to validate this missense mutation with a low frequency (<1%), and then carried out a genetic association analysis involving 3299 unrelated individuals (1447 with SCZ, 380 with ASD, and 1472 healthy controls) to clarify whether A33T was associated with SCZ or ASD. A33T was not found in either case group, and in only one control. We did not find evidence that p.A33T is involved in the onset of ASD or SCZ; however, associations with this variant need to be evaluated in larger samples to confirm our results.

    DOI: 10.18999/nagjms.84.2.260

    Web of Science

    Scopus

    PubMed

  9. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder Reviewed International journal

    Itaru Kushima, Masahiro Nakatochi, Branko Aleksic, Takashi Okada, Hiroki Kimura, Hidekazu Kato, Mako Morikawa, Toshiya Inada, Kanako Ishizuka, Youta Torii, Yukako Nakamura, Satoshi Tanaka, Miho Imaeda, Nagahide Takahashi, Maeri Yamamoto, Kunihiro Iwamoto, Yoshihiro Nawa, Nanayo Ogawa, Shuji Iritani, Yu Hayashi, Tzuyao Lo, Gantsooj Otgonbayar, Sho Furuta, Nakao Iwata, Masashi Ikeda, Takeo Saito, Kohei Ninomiya, Tomo Okochi, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Michiko Fujimoto, Kenichiro Miura, Masanari Itokawa, Makoto Arai, Mitsuhiro Miyashita, Kazuya Toriumi, Kazutaka Ohi, Toshiki Shioiri, Kiyoyuki Kitaichi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Tsukasa Sasaki, Mamoru Tochigi, Fumichika Nishimura, Hidenori Yamasue, Hitoshi Kuwabara, Tomoyasu Wakuda, Takahiro A. Kato, Shigenobu Kanba, Hideki Horikawa, Masahide Usami, Masaki Kodaira, Kyota Watanabe, Takeo Yoshikawa, Tomoko Toyota, Shigeru Yokoyama, Toshio Munesue, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Minyoung Jung, Kiyoto Kasai, Tempei Ikegame, Seiichiro Jinde, Shusuke Numata, Makoto Kinoshita, Tadafumi Kato, Chihiro Kakiuchi, Kazuhiro Yamakawa, Toshimitsu Suzuki, Naoki Hashimoto, Shuhei Ishikawa, Bun Yamagata, Shintaro Nio, Toshiya Murai, Shuraku Son, Yasuto Kunii, Hirooki Yabe, Masumi Inagaki, Yu-ichi Goto, Yuto Okumura, Tomoya Ito, Yuko Arioka, Daisuke Mori, Norio Ozaki

    Biological Psychiatry   Vol. 92 ( 5 ) page: 362 - 374   2022.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier {BV}  

    BACKGROUND: We aimed to determine the similarities and differences in the roles of genic and regulatory copy number variations (CNVs) in bipolar disorder (BD), schizophrenia (SCZ), and autism spectrum disorder (ASD). METHODS: Based on high-resolution CNV data from 8708 Japanese samples, we performed to our knowledge the largest cross-disorder analysis of genic and regulatory CNVs in BD, SCZ, and ASD. RESULTS: In genic CNVs, we found an increased burden of smaller (<100 kb) exonic deletions in BD, which contrasted with the highest burden of larger (>500 kb) exonic CNVs in SCZ/ASD. Pathogenic CNVs linked to neurodevelopmental disorders were significantly associated with the risk for each disorder, but BD and SCZ/ASD differed in terms of the effect size (smaller in BD) and subtype distribution of CNVs linked to neurodevelopmental disorders. We identified 3 synaptic genes (DLG2, PCDH15, and ASTN2) as risk factors for BD. Whereas gene set analysis showed that BD-associated pathways were restricted to chromatin biology, SCZ and ASD involved more extensive and similar pathways. Nevertheless, a correlation analysis of gene set results indicated weak but significant pathway similarities between BD and SCZ or ASD (r = 0.25-0.31). In SCZ and ASD, but not BD, CNVs were significantly enriched in enhancers and promoters in brain tissue. CONCLUSIONS: BD and SCZ/ASD differ in terms of CNV burden, characteristics of CNVs linked to neurodevelopmental disorders, and regulatory CNVs. On the other hand, they have shared molecular mechanisms, including chromatin biology. The BD risk genes identified here could provide insight into the pathogenesis of BD.

    DOI: 10.1016/j.biopsych.2022.04.003

    Web of Science

    Scopus

    PubMed

  10. Sequencing of selected chromatin remodelling genes reveals increased burden of rare missense variants in ASD patients from the Japanese population Reviewed

    Tzuyao Lo, Itaru Kushima, Branko Aleksic, Hidekazu Kato, Yoshihiro Nawa, Yu Hayashi, Gantsooj Otgonbayar, Hiroki Kimura, Yuko Arioka, Daisuke Mori, Norio Ozaki

    International Review of Psychiatry   Vol. 34 ( 2 ) page: 154 - 167   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Informa UK Limited  

    DOI: 10.1080/09540261.2022.2072193

    Web of Science

    Scopus

    PubMed

  11. Resequencing and association analysis of GAP43 with autism spectrum disorder and schizophrenia in a Japanese population

    Arta Reza K., Watanabe Yuichiro, Inoue Emiko, Nawa Yoshihiro, Morikawa Ryo, Egawa Jun, Kushima Itaru, Igeta Hirofumi, Hoya Satoshi, Sugimoto Atsunori, Tanra Andi J., Ozaki Norio, Someya Toshiyuki

    RESEARCH IN AUTISM SPECTRUM DISORDERS   Vol. 82   2021.4

     More details

    Publisher:Research in Autism Spectrum Disorders  

    DOI: 10.1016/j.rasd.2021.101729

    Web of Science

    Scopus

  12. Rare genetic variants in the gene encoding histone lysine demethylase 4C (KDM4C) and their contributions to susceptibility to schizophrenia and autism spectrum disorder Reviewed

    Hidekazu Kato, Itaru Kushima, Daisuke Mori, Akira Yoshimi, Branko Aleksic, Yoshihiro Nawa, Miho Toyama, Sho Furuta, Yanjie Yu, Kanako Ishizuka, Hiroki Kimura, Yuko Arioka, Keita Tsujimura, Mako Morikawa, Takashi Okada, Toshiya Inada, Masahiro Nakatochi, Keiko Shinjo, Yutaka Kondo, Kozo Kaibuchi, Yasuko Funabiki, Ryo Kimura, Toshimitsu Suzuki, Kazuhiro Yamakawa, Masashi Ikeda, Nakao Iwata, Tsutomu Takahashi, Michio Suzuki, Yuko Okahisa, Manabu Takaki, Jun Egawa, Toshiyuki Someya, Norio Ozaki

    Translational Psychiatry   Vol. 10 ( 1 ) page: 421   2020.12

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41398-020-01107-7

    Web of Science

    Scopus

    PubMed

  13. Rare single-nucleotide DAB1 variants and their contribution to Schizophrenia and autism spectrum disorder susceptibility Reviewed

    Yoshihiro Nawa, Hiroki Kimura, Daisuke Mori, Hidekazu Kato, Miho Toyama, Sho Furuta, Yanjie Yu, Kanako Ishizuka, Itaru Kushima, Branko Aleksic, Yuko Arioka, Mako Morikawa, Takashi Okada, Toshiya Inada, Kozo Kaibuchi, Masashi Ikeda, Nakao Iwata, Michio Suzuki, Yuko Okahisa, Jun Egawa, Toshiyuki Someya, Fumichika Nishimura, Tsukasa Sasaki, Norio Ozaki

    Human Genome Variation   Vol. 7 ( 1 ) page: 37   2020.12

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media {LLC}  

    DOI: 10.1038/s41439-020-00125-7

    Web of Science

    Scopus

    PubMed

▼display all

MISC 7

  1. DSM-5-TR 精神疾患の診断・統計マニュアル

    日本精神神経学会(監修)( 担当:共訳)

    医学書院     2023.9

  2. Three cases of neurofibromatosis type 1 (NF1) with neurodevelopmental disorders-A clinical practice of child and adolescent psychiatry in in-hospital clinical network for NF1-

    冨田伊吹季, 名和佳弘, 久島周, 久島周, 高橋長秀, 城所博之, 西田佳弘, 加藤秀一

    日本レックリングハウゼン病学会学術大会プログラム・抄録集(CD-ROM)   Vol. 14th   2023

     More details

  3. A case of attention deficit hyperactivity symptoms after hemorrhage of cerebral arteriovenous malformation

    大野由佳, 名和佳弘, 加藤秀一, 高橋長秀

    日本生物学的精神医学会(Web)   Vol. 45th   2023

     More details

  4. うつ病診療ガイドライン ー児童思春期うつ病への個別性に配慮した対応を中心にー

    名和 佳弘, 尾崎 紀夫

    臨床と研究   Vol. 99 ( 5 ) page: 11 - 16   2022.5

  5. ゲノム医学からみた総合失調症 ー病態に基づく診断体系構築に向けて

    名和 佳弘, 木村 大樹, 尾崎 紀夫

    そだちの科学   ( 36 ) page: 11 - 17   2021.4

  6. 自閉スペクトラム症多発家系における遺伝カウンセリングを通じて父親の自責感が軽減した一例

    加藤秀一, 加藤秀一, 石塚佳奈子, 名和佳弘, 名和佳弘, 木村大樹, 久島周, 久島周, 高橋長秀, 高橋長秀, 尾崎紀夫, 尾崎紀夫, 尾崎紀夫

    日本児童青年精神医学会総会抄録(Web)   Vol. 62nd   2021

     More details

  7. 既知の遺伝子疾患と関連する神経発達症・統合失調症

    名和 佳弘, 久島 周, 尾崎 紀夫

    臨床精神医学   Vol. 48 ( 1 ) page: 53 - 61   2019.1

     More details

    Language:Japanese  

▼display all

Presentations 8

  1. 3q29欠失を有し統合失調症と診断された4症例

    名和佳弘, 久島周, 加藤秀一, 木村大樹, 阪野正大, 橋本亮太, 菱本明豊, 尾崎紀夫

    日本児童青年精神医学会総会  2021 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

  2. Investigation of rare single-nucleotide DAB1 variants and its contribution to schizophrenia and autism spectrum disorder susceptibility.

    Nawa Yoshihiro, Hiroki Kimura, Kanako Ishizuka, Itaru Kushima, Branko Aleksic, Norio Ozaki

    World Congress of Psychiatric Genetics-WCPG2019  2019 

  3. 統合失調症と自閉スペクトラム症におけるDAB1遺伝子内の稀な一塩基変異の探索

    名和佳弘, 木村大樹, 石塚佳奈子, 久島周, アレクシッチ・ブランコ, 尾崎紀夫

    日本精神神経学会学術総会  2019 

  4. COVID-19パンデミック前後での児童思春期摂食障害患者の臨床像の変化

    松井健, 加藤秀一, 名和佳弘, 今枝美穂, 高橋長秀

    第64回児童青年精神医学会  2023 

  5. Genetic Counseling for ASD in Child Psychiatry: A Singleton’s Case and Cases in a Multiplex Family.

    Hidekazu Kato, Yoshihiro Nawa, Kanako Ishizuka, Hiroki Kimura, Itaru Kushima, Nagahide Takahashi, Norio Ozaki

    the 25th World Congress of International Association for Child and Adolescent Psychiatry and Allied Professions' (IACAPAP).  2022 

  6. 神経発達症を併存する神経線維腫症1型の3例 ―NF1院内診療ネットワークにおける児童精神科の臨床実践から―

    冨田伊吹季, 名和佳弘, 久島周, 高橋長秀, 城所博之, 西田佳弘, 加藤秀一

    第14回レックリングハウゼン病学会  2023 

  7. 緊張病とその後の機能低下を認めたのち急激な症状改善を認めた自閉スペクトラム症の一女児例

    寺嶋彰子, 加藤秀一, 名和佳弘, 小川しおり, 河村雄一, 高橋長秀, 尾崎紀夫

    第63回児童青年精神医学会  2022 

  8. 薬物療法と父親が自作した暴露反応妨害法の教材を用いた認知行動療法で著明に改善した児童の強迫症の症例

    伊上敬哉, 名和佳弘, 池田匡志

    第182回東海精神神経学会  2024 

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 1

  1. 神経線維腫症1型における遺伝型と精神医学的表現型の解析-早期発見と介入を目指して

    Grant number:23K14798  2023.4 - 2026.3

    日本学術振興会  科学研究費助成事業  若手研究

    名和 佳弘

      More details

    Authorship:Principal investigator 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    神経線維腫症1型(NF1)は、皮膚、神経系など多種病変が出現する単一遺伝子疾患であり、神経発達症の併存率が高い。しかし、予後予測の困難さから早期発見、早期介入が不十分であり、二次障害に繋がっている可能性がある。NF1は、発症に至るNF1上のバリアントとその結果現れる表現型との相関が不詳であるため、ゲノムバリアントを起点とした予後予測、病態解明、新規治療法の開発の遅れの一因となっている。本研究では、NF1患者を対象に、シークエンス解析と神経発達症や精神症状の詳細な臨床表現型の評価を行うことで、遺伝型-表現型の相関を明確化し、NF1患者における神経発達症の早期発見、早期介入に繋げることを目指す。